Physician profile
Jonathan M Winter
NPI 1922028950
$1,048.99
in general payments reported to CMS, 2019-2025
16 companies · $314 in 2025
The $314 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $13.06 · 2022: $86.36 · 2023: $98.51 · 2024: $374 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $786.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $786.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Journey Medical Corporation | $237.45 | 2024-2025 | |
| Pfizer INC. | $163.02 | 2022-2024 | |
| Sun Pharmaceutical Industries INC. | $155.52 | 2023-2025 | Winlevi |
| Almirall LLC | $145.34 | 2024 | Klisyri |
| Janssen Biotech, INC. | $84.60 | 2019 | |
| Epi Health, LLC | $70.36 | 2022 | |
| Janssen Scientific Affairs, LLC | $49.61 | 2019 | |
| Amgen INC. | $18.57 | 2025 | Otezla |
| Genzyme Corporation | $16.90 | 2023 | |
| Abbvie INC. | $16.83 | 2023 | Rinvoq |
| Arcutis Biotherapeutics, INC. | $16.28 | 2024 | Zoryve |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.21 | 2024 | Cabtreo |
| Lnhc, INC | $15.90 | 2025 | Zelsuvmi |
| Regeneron Healthcare Solutions, INC. | $14.93 | 2019 | |
| Merck Sharp & Dohme LLC | $14.41 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vyne Pharmaceuticals INC. | $13.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Winter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.